UNITY BIOTECHNOLOGY INC (UBX) 2.74 -0.19 (-6.48%)
2.74 -0.19 (-6.48%)
US91381U2006 - Common Stock
Buy % Consensus
Analysts have set a mean price target of 34.51. This target is 1159.49% above the current price.
UBX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about UBX.
In the previous month the buy percentage consensus was at a similar level.
UBX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-16 | Mizuho | Maintains | Buy |
| 2022-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-02 | Wedbush | Maintains | Outperform |
| 2022-08-16 | Mizuho | Maintains | Buy |
| 2022-08-15 | Citigroup | Maintains | Buy |
| 2022-05-17 | Citigroup | Maintains | Buy |
| 2022-01-04 | Roth Capital | Upgrade | Neutral -> Buy |
| 2021-11-10 | Mizuho | Upgrade | Neutral -> Buy |
| 2021-06-28 | Citigroup | Upgrade | Sell -> Buy |
| 2021-06-07 | HC Wainwright & Co. | Initiate | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA